Injectable cabotegravir and rilpivirine should not be used with: the anticonvulsants carbamazepine, oxcarbazepine, phenobarbital, phenytoin the antimycobacterials rifabutin, rifampicin, rifapentine ...
The WHO says that 490,000 people have multidrug-resistant tuberculosis (MDR-TB), when bacteria do not respond to the two most powerful first-line anti-TB drugs, isoniazid and rifampicin.
Health-related stigma plays a significant role in the burden of various health conditions such as neglected tropical diseases and mental illnesses, and undermines successful health outcomes.